Trials / Recruiting
RecruitingNCT06186934
Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Kyowa Kirin Korea Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The objective of this post-marketing surveillance (PMS) study is to assess the safety and effectiveness of Nephoxil capsule 500 mg (Ferric Citrate 500 mg, equivalent to 105 mg Ferric Iron) in routine clinical settings
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | the standard-dose group (4 g/day) | Patients with chronic kidney disease undergoing hemodialysis and controlling hyperphosphatemia |
Timeline
- Start date
- 2023-12-21
- Primary completion
- 2026-01-30
- Completion
- 2026-01-30
- First posted
- 2024-01-02
- Last updated
- 2024-04-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06186934. Inclusion in this directory is not an endorsement.